ARCHIVES

Senate Committee Directs NCI To Conduct Research To Eliminate Barriers To Enrollment On Clinical Trials.

This article is from The Cancer Letter archive.

Vol. 33 No. 26 | July 6, 2007

Download PDF Visit The Full Archive

Related Articles

In Brief: Senate Committee Cuts House Amount For NCI; NCI Staff Faces Up to 22 Days Unpaid Leave

September 21, 1990

ODAC Advises Approval Of Tamoxifen For Male Breast Cancer Treatment

November 27, 1992

SAIC Awarded $5 Billion Contract For NCI-Frederick.

October 3, 2008

Army Accepting Letters of Intent For Research in Breast Cancer; Plans Announcement In Sept.

July 16, 1993

New DRCCA Board Skeptical Of CIs renewal, Proposal For Cytopathology

September 26, 1980

Study Of Tamoxifen And Raloxifene Enrolls 6,000 In First Year; 5 Percent Are Minorities

July 28, 2000